首页 | 本学科首页   官方微博 | 高级检索  
     


Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised,double-blind,placebo-controlled,phase 1 trial
Authors:Petr Novak  Reinhold Schmidt  Eva Kontsekova  Norbert Zilka  Branislav Kovacech  Rostislav Skrabana  Zuzana Vince-Kazmerova  Stanislav Katina  Lubica Fialova  Michal Prcina  Vojtech Parrak  Peter Dal-Bianco  Martin Brunner  Wolfgang Staffen  Michael Rainer  Matej Ondrus  Stefan Ropele  Miroslav Smisek  Michal Novak
Affiliation:1. AXON Neuroscience SE, Bratislava, Slovakia;2. Clinical Division of Neurogeriatrics, Department of Neurology, Medical University Graz, Graz, Austria;3. Division of General Neurology, Department of Neurology, Medical University Graz, Graz, Austria;4. University Clinic of Neurology, Medical University of Vienna, Vienna, Austria;5. University Clinic of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria;6. University Clinic of Neurology, Christian-Doppler-Clinic, Salzburg, Austria;7. Social and Medical Centre East, Danube Hospital, Karl Landsteiner Institute for Memory and Alzheimer Research, Vienna, Austria;8. Karolinska Institute Alzheimer Disease Research Centre and Clinical Trial Unit, Geriatric Clinic, Karolinska University Hospital, Huddinge, Sweden
Abstract:
Keywords:Correspondence to: Dr Petr Novak   AXON Neuroscience SE   811 02 Bratislava   Slovakia
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号